Posted by Michael Wonder on 16 May 2022
Insulin producers face fresh lawsuit in US over pricing
13 May 2022 - Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers – Eli Lilly, Sanofi and Novo Nordisk – accusing them of deceptively driving up the price of the medicines.
It has filed a lawsuit that accuses the drug makers and pharmacy benefit managers Express Scripts, Caremark and OptumRx of conspiring to manipulate and inflate insulin prices in the state, inflating their profits and making the drugs unaffordable for many diabetics.
